Guo Jing, Zheng Hui Juan, Zhang Wenting, Lou Wenjiao, Xia Chenhui, Han Xue Ting, Huang Wei Jun, Zhang Fan, Wang Yaoxian, Liu Wei Jing
Renal Research Institution; Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing 100700, China.
Institute of Nephrology, and Zhanjiang Key Laboratory of Prevention and Management of Chronic Kidney Disease, Guangdong Medical University, No. 57th South Renmin Road, Zhanjiang, Guangdong 524001, China.
Oxid Med Cell Longev. 2020 Jul 27;2020:1234059. doi: 10.1155/2020/1234059. eCollection 2020.
With aging, the kidney undergoes inexorable and progressive changes in structural and functional performance. These aging-related alterations are more obvious and serious in diabetes mellitus (DM). Renal accelerated aging under DM conditions is associated with multiple stresses such as accumulation of advanced glycation end products (AGEs), hypertension, oxidative stress, and inflammation. The main hallmarks of cellular senescence in diabetic kidneys include cyclin-dependent kinase inhibitors, telomere shortening, and diabetic nephropathy-associated secretory phenotype. Lysosome-dependent autophagy and antiaging proteins Klotho and Sirt1 play a fundamental role in the accelerated aging of kidneys in DM, among which the autophagy-lysosome system is the convergent mechanism of the multiple antiaging pathways involved in renal aging under DM conditions. Metformin and the inhibitor of sodium-glucose cotransporter 2 are recommended due to their antiaging effects independent of antihyperglycemia, besides angiotensin-converting enzyme inhibitors/angiotensin receptor blockers. Additionally, diet intervention including low protein and low AGEs with antioxidants are suggested for patients with diabetic nephropathy (DN). However, their long-term benefits still need further study. Exploring the interactive relationships among antiaging protein Klotho, Sirt1, and autophagy-lysosome system may provide insight into better satisfying the urgent medical needs of elderly patients with aging-related DN.
随着年龄的增长,肾脏在结构和功能表现上会发生不可避免的渐进性变化。这些与衰老相关的改变在糖尿病(DM)中更为明显和严重。糖尿病条件下肾脏的加速衰老与多种应激有关,如晚期糖基化终产物(AGEs)的积累、高血压、氧化应激和炎症。糖尿病肾脏细胞衰老的主要标志包括细胞周期蛋白依赖性激酶抑制剂、端粒缩短和糖尿病肾病相关的分泌表型。溶酶体依赖性自噬以及抗衰老蛋白α-klotho和沉默信息调节因子1(Sirt1)在糖尿病肾脏加速衰老中起重要作用,其中自噬-溶酶体系统是糖尿病条件下参与肾脏衰老的多种抗衰老途径的汇聚机制。除血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂外,由于二甲双胍和钠-葡萄糖协同转运蛋白2抑制剂具有独立于抗高血糖的抗衰老作用,因此也被推荐使用。此外,建议糖尿病肾病(DN)患者进行饮食干预,包括低蛋白、低AGEs饮食并补充抗氧化剂。然而,它们的长期益处仍需进一步研究。探索抗衰老蛋白α-klotho、Sirt1与自噬-溶酶体系统之间的相互关系,可能有助于更好地满足老年糖尿病肾病患者的迫切医疗需求。